Elizabeth Roboz Einstein's journey began on May 15, 1940, when she boarded the Conte di Savoia, an Italian steamliner, leaving behind her family in Hungary as World War II escalated. This voyage was not a luxury cruise but a desperate evacuation for many, including 600 Central European refugees fleeing the advancing German troops.
Helical's thesis is that bio foundation models, AI systems trained on vast genomic, transcriptomic, and proteomic datasets, have already crossed a quality threshold that makes computational hypothesis-testing meaningful in pharma research.
While some other creatures, most notably salamanders and starfish, can regenerate entire limbs, mammals don't have this evolutionary superpower. The big question is: Why are mammals limited?
GPT-Rosalind is designed to support evidence synthesis, hypothesis generation, experimental planning, and multi-step scientific workflows across biochemistry, genomics, and protein engineering.
Incyte tops this list due to its rare combination of commercial scale, cash generation, and pipeline depth. The company posted FY2025 revenue of $5.14 billion, up 21.2% YoY, anchored by Jakafi generating $828.2 million in Q4 2025 alone (+7% YoY) and Opzelura delivering $207.3 million (+28% YoY). With $3.58 billion in cash and 14 pivotal clinical trials underway, Incyte offers an acquirer immediate revenue, margin expansion potential, and a deep oncology pipeline spanning KRASG12D, CDK2 inhibition, and mutCALR.
Chronic inflammation is a central driver of pathological fibrosis after ischaemic or haemodynamic stress, but strategies that locally rebalance injurious and reparative immune responses without systemic immunosuppression are lacking.
January 22, 2026 2 min read Add Us On GoogleAdd SciAm The National Institutes of Health's move to end support for research using fetal human tissue is clearly a political decision, not a scientific one, one expert says By Dan Vergano edited by Claire Cameron National Institutes of Health director Jay Bhattacharya speaks at the National Conservatism Conference in Washington, D.C., in 2025.
When mitochondria are exposed to tissue or blood, they lose the electrical gradient across their outer membrane. Mitochondria that lack such a gradient are recognized by a cell's internal machinery as damaged and quickly destroyed. The vast majority of previous studies involved injecting 'naked' mitochondria directly into the bloodstream or tissue sites, but the approach isn't very efficient, so researchers often have to use 'ridiculous' doses of mitochondria.
Martschenko's argument is largely that genetic research and data have almost always been used thus far as a justification to further entrench extant social inequalities. But we know the solutions to many of the injustices in our world-trying to lift people out of poverty, for example-and we certainly don't need more genetic research to implement them. Trejo's point is largely that more information is generally better than less.
Biology is undergoing a transformation. After centuries of studying life as it evolves naturally, researchers are now using a combination of computation and genome engineering to intervene, generating new proteins and even whole bacteria from scratch. The use of artificial-intelligence tools to design biological components, an approach known as generative biology, is set to turbocharge this area of research. Just last year, scientists used AI-assisted design to produce artificial genes that can be expressed in mammalian cells.
'Stem cell-based' treatments and just the latest aesthetic treatment marketed to those seeking to maintain or obtain youthful skin, but what exactly is involved and what's the evidence that they work It's hard to keep track of the number of scientifically based beauty treatments on offer these days. Most are aimed at middle-aged females with disposable incomes, who are willing to splash large amounts of money on their skin to counter the effects of time.